麻豆传媒

Halden is director of the Center for Environmental Health Engineering at the Biodesign Institute, professor in the Ira A. Fulton School for Sustainable Engineering and the Built Environment, and a senior sustainability scientist.

Joined University of Maryland in 2005.

Henry C. Boyd is a Clinical Professor in the Marketing Department at the Robert H. Smith School of Business. He is also a managing director and principal at Ombudsman LLC, a diversified consultancy. He is licensed to practice law in Maryland, Wisconsin, and the U.S. District Court, Western District of Wisconsin. 

Boyd received his Ph.D. in Marketing from Duke University (with an emphasis in Consumer Behavior) and his J.D. in Intellectual Property from the University of Wisconsin-Madison. At the age of 24, he received his MBA in Marketing from the University of California at Berkeley. Prior to graduate study, he obtained his A.B. in Chemistry (with an emphasis in Biophysics) from Princeton University.

Boyd鈥檚 areas of expertise include biotechnology, consumer behavior, business consulting, pharmaceutical sales, advertising, and market research. His research has been published in Marketing Letters, Psychology & Marketing, and Journal of Advertising Research. He has served as an ad hoc reviewer for the Journal of Marketing Research. He has critiqued pedagogical approaches found in marketing textbooks for such leading publishing houses as CENGAGE, Prentice Hall, and Thomson South-Western.

Boyd鈥檚 opinions have appeared in The Washington Post, Baltimore Sun, Washington Times, Wisconsin State Journal, Capital Times, and Wausau Daily Herald. He has participated in live interviews on Maryland Public Television, CBS 麻豆传媒 (local affiliate WISC-TV Channel 3 麻豆传媒), NBC 麻豆传媒 (local affiliate WMTV Channel 15 麻豆传媒), and NEWS/TALK 1310 WIBA RADIO.

During the course of his academic career, Boyd has taught over 17,500 students the intricacies of marketing theory and practice. Outside of academe, he has worked as a summer associate at Heller Ehrman, a pharmaceutical rep at Merck, and an economic forecaster at IBM. He has consulted with several executive clients including the NFL, ExxonMobil, SAIC, Verizon, Stanley Black & Decker, and Ocean Tomo. At times, he has been called upon as an expert witness in legal proceedings. He has served on the faculty of the University of Wisconsin-Madison.

Boyd resides in Fulton, MD with his wife, Isabel, and his daughter, Giselle.

Joshua LaBaer is renowned for his work in proteomics and developing biomarker diagnostics. He leads ASU's COVID-19 research efforts. 

As executive director of the Biodesign Institute, his work emphasizes that multidisciplinary factors culminate to disease, suggesting personalized therapies and unique biomarker analysis. His team uses arrays to assess how programmable a protein is. This work also spans into epigenetics, and the capacity to modulate the activity of these proteins.

LaBaer was the founder and director of Harvard's Institute of Proteomics and a chairman of the Virginia G. Piper Center for Personalized Diagnostics. He is an associate editor of the Journal of Proteome Research, a member of the National Cancer Institute's Board of Scientific Advisors, chair of the Early Detection Research Network Steering Committee and recent president of the U.S. Human Proteome Organization.

Gardini studies the epigenetic control of transcription during cell differentiation and oncogenesis.

Born and raised in Italy, Gardini obtained a B.S./M.S. in medical biotechnology at the University of Bologna and attended the graduate school of Molecular Medicine at the University of Milan. He trained as a postdoctoral fellow with Dr. Ramin Shiekhattar at the Center of Genomic Regulation in Barcelona, The Wistar Institute and the University of Miami Medical School. He joined Wistar as an assistant professor in 2015. Gardini is a scholar of the Leukemia Research Foundation and the American Cancer Society.

Biotechnology; bioengineering; chemical engineering; metabolic engineering; systems biology; synthetic biology; computational biology; bioinformatics; cheminformatics; functional genomics; mathematical modeling; optimization; anaerobic microbiology; and environmental microbiology.

Trained as a bioengineer, Dr. Islam鈥檚 research focuses on the design, re-design, and implementation of biological processes to tackle important societal challenges, including the bioproduction of 鈥榞reen鈥� petrochemicals from gases, mitigating nutrient pollution from the environment, and developing novel chemotherapies for cancer treatment. He uses both computational and experimental approaches to engineer 鈥榗ellular metabolism,鈥� namely bioprocesses, to achieve the research objectives.

Steve Long has served as Principal Investigator and Director of the Realizing Increased Photosynthetic Efficiency (RIPE) Project since its inception in 2012.  He is the Ikenberry Endowed Chair of Plant Biology and Crop Sciences at the University of Illinois. Steve's research has increased our understanding of how global climate change is affecting plants and how photosynthetic efficiency in crops may be improved to effect sustainable yield increases. His expertise ranges from plant molecular biology and mathematical modeling to in silico crop design and field analyses of the impacts of atmospheric change and transgenic modifications of photosynthesis on crop performance. Steve is also the director of Renewable Oil Generated with Ultra-productive Energycane (ROGUE) He served as Deputy Director of the UC Berkeley-U Illinois-BP Energy Biosciences Institute (EBI) until 2012. He is Founding and Chief Editor of Global Change Biology, of GCB Bioenergy and of in silico Plants. 

Steve was elected a Fellow of the Royal Society of London in 2013 and as a Member of the National Academy of Science of the United States of America in 2019.  He has been recognized by Thomson Reuters/Clarivate as a highly cited researcher in Plant and Animal Sciences in every year from 2005 to 2021. His work has been published in more than 400 peer-reviewed journals, including Nature and Science. He has been recognized with many awards, including the Marsh Award for Climate Change Research from the British Ecological Society, the Kettering Award from the American Society of Plant Biologists, the Innovation Award from the International Society for Photosynthesis Research and the Graduate Student Mentoring Award of the University of Illinois. He served as the Newton-Abraham Visiting Professor at Oxford University, UK, where he retains a Visiting Professorship. He has given briefings on food security and bioenergy to President George W. Bush at the White House, to the Vatican, and to Bill Gates. He earned his bachelor鈥檚 in agriculture from Reading University and his doctorate in plant sciences from Leeds University.

Realizing increased Photosynthetic (RIPE) Project Deputy Director Donald Ort is the Robert Emerson Professor in Plant Biology and Crop Sciences at the University of Illinois. His research seeks to understand and improve plant growth and photosynthetic performance in changing environmental conditions, such as increasing CO2 temperature and drought. Don's research ranges from improving photosynthetic efficiency to the molecular and biochemical basis of environmental interactions with crop plants to ecological genomics. His research spans from the molecular to crop canopies in the field. Don earned his bachelor鈥檚 degree in biology from Wake Forest University and his doctorate in plant biochemistry from Michigan State University. He has served as the president of the American Society of Plant Biologists, the International Society of Photosynthesis Research, and the International Association of Plant Physiology. He also served as editor-in-chief of Plant Physiology and is an associate editor of Annual Review of Plant Biology. Don has received numerous awards and recognitions, including election to the National Academy of Sciences and being named one of Thomson Reuters鈥� Most Influential Scientific Minds. He has published over 250 peer-reviewed papers in journals that include Science.

Dr. Scott E. Baker leads the . His research interests include biotechnology, genomics, and genetics, especially as they relate to fungal metabolite production, enzyme secretion, and cell morphology. Baker has a joint appointment as a fungal biotechnology scientist with the U.S. Department of Energy (DOE) Joint BioEnergy Institute (JBEI) located in Emeryville, California. At JBEI, his research is focused on heterologous production of lignin active enzymes by fungi.
For more than a decade he has led and contributed to fungal genome projects, from single genomes, to resequencing of classical genetic mutant strains, to whole fungal genus sequencing efforts. In 2009 and 2010, with DOE Joint Genome Institute (JGI) staff members, he co-led the development and launch of the JGI Fungal Genomics Program.
Baker has served on the Board of Directors of Society for Industrial Microbiology and Biotechnology (SIMB) as both a Director and President, and is a recent SIMB Fellow. He has contributed to nine journals as a reviewer, has been on the editorial board for the Industrial Biotechnology journal since 2011, and guest edited numerous special edition journals.

Research Interests


Biotechnology
Biofuels and chemicals
Microbiology
Mycology


Education


PhD in Cell and Molecular Biology, Northwestern University, 1996
BS in Biology, Oregon State University, 1992

Dr. Alexander Beliaev leads EMSL's . He is also the Synthetic Biology team leader for Pacific Northwest National Laboratory's Biological Sciences Division. His expertise and interests span systems microbiology, functional genomics, synthetic biology, and biotechnology.
Over the last two decades, Beliaev’s work has focused on predictive understanding of energy and materials conversion by microbes with emphasis on metabolic and regulatory controls guiding these processes. He has led and co-led multi-institutional projects focusing on the diversity of microbial metabolism: from extracellular electron transfer in chemolithotrophic bacteria to photosynthetic energy capture in oxygenic phototrophs. This work led to the discovery of the molecular basis of dissimilatory metal reduction by marine and subsurface microorganisms, as well as to development of a broad understanding of mechanisms by which cyanobacteria maximize energy conversion to achieve ultrahigh growth. His academic and educational accomplishments have also led to a joint appointment with the Centre for Agriculture and the Bioeconomy at the Queensland University of Technology, where he serves as a professor of biotechnology.
Today, Beliaev is exploring fundamental mechanisms and design principles that govern the functioning of multi-species systems. He is incorporating cutting-edge measurement technologies into systems and synthetic biology approaches, especially with respect to microbial community function and host-microbe interactions, to take knowledge from the laboratory to the field and translate it into industrial applications and partnerships with industry.

Dr. Lisa Waidner, an Assistant Professor, has a Ph.D. from the College of Marine Science at the University of Delaware. Before she joined UWF in 2016, Waidner had the unique opportunity to work in several small biotechnology companies in the capacity of genetic engineering, phylogenetics, and directed evolution to improve biofuel and bioenergy-producing microorganisms.  Her academic mentors were Richard Karpel (UMBC, M.S. program), David Kirchman (Delaware, Ph.D. program), Thomas Hanson (Delaware, post-doctoral position), and co-mentors Robin Morgan and Joan Burnside (Delaware, post-doctoral fellowship). 
Her findings have been published in the Journal of Shellfish Research, Applied and Environmental Microbiology, Virology, and Environmental Virology. Topics have included aspects of Marek’s disease, virioplankton populations, and crab populations near the mouth of the Delaware Bay. Waidner’s current research interests are in environmental microbiology, microbial ecology, and bioremediation in oceans, coastal waters, inland bays, and rivers. 
These studies include developing a better understanding of global elemental cycles, as well as ‘applied’ bioremediation research.  Her work uses model bacteria called the aerobic anoxygenic phototrophs (AAP), which are a diverse group of proteobacteria that may be involved in light-stimulated uptake of dissolved organic matter and of point-source pollution and legacy contaminants.  Cultured and uncultured AAP are used in molecular biological, microbiological, and ecological studies on this diverse group of freshwater, estuarine, and marine bacteria. Dr. Waidner has taught classes in Introduction to Bioinformatics and Environmental Genomics and is currently a UWF instructor for Genetics Lab.  She is now working with undergraduate students to characterize unique AAP bacteria from coastal and inland waters in and around the Pensacola Bay system.

Dr. William Greene’s leadership positions have included founder, biotechnology executive, investor, and clinician. As CEO, he built Iconic Therapeutics through discovery, clinical development and venture financing, leading to a successful sale of the company. He later helmed longevity biotech company Fountain Therapeutics and co-founded digital therapeutics startup Pear Therapeutics. 
Dr. Greene spent 12 years at MPM Capital where he was a Managing Director and member of its Investment Committee, responsible for biotechnology and medical technology investments worldwide. He was also founding Chairman and head of the Investment Committee at the Global Health Investment Fund, a groundbreaking impact-oriented venture fund in collaboration with the Gates Foundation, which successfully scaled both investment returns and health impact simultaneously. 
Earlier in his career, Dr. Greene was an Assistant Professor of Medicine at University of California at San Francisco (UCSF) and led clinical trials and strategy for a variety of therapeutic areas at Genentech. 
Dr. Greene earned his BA from Wesleyan University and his MD from UCSF. He was a Robert Wood Johnson Clinical Scholar at Yale and a Howard Hughes Medical Institute Research Scholar at the US National Institutes of Health (NIH).

 
Brenda Anne Wilson is a Professor of microbiology in the School of Molecular & Cellular Biology at the University of Illinois Urbana-Champaign. She also is the Inaugural Professor of Biomedical and Translational Sciences in the Carle Illinois College of Medicine, an adjunct professor of pathobiology in the College of Veterinary Medicine; and the Sandia Senior Faculty Fellow in the university's Office of the Vice Chancellor for Research and Innovation. 
Wilson is a fellow of the American Academy of Microbiology and a member of the AAM Selection Committee, and an American Society for Microbiology Distinguished Lecturer.
She was a DAAD graduate exchange Fellow in biochemistry at Ludwig-Maximilians Universität München, Germany. While earning her PhD at Johns Hopkins University, she was an AAUW doctoral fellow and studied antibiotic biosynthesis. She then undertook her NIH postdoctoral fellowship training in microbiology at Harvard Medical School, where she began her studies on bacterial protein toxins. Her first tenured faculty appointment was in biochemistry at Wright State University School of Medicine, Dayton, Ohio.
As inaugural leader of the Host-Microbe Systems Theme of the Woese Institute for Genomic Biology at the University of Illinois for 10 years, Wilson brought together faculty and scientists from multiple disciplines across campus, including microbiology, anthropology, animal sciences, engineering, and veterinary pathobiology to forge new areas of microbiome research. She served for 10 years on the executive committee of the Great Lakes Regional Center for Excellence in Biodefense and Emerging Infectious Diseases. As co-director of the University of Illinois Center for Zoonoses Research, she has promoted the One-Health Initiative and training of DVM students in research through summer training experiences. For nearly 20 years she has served as Biosecurity Leader of the Executive Committee of the University of Illinois Program in Arms Control, Domestic and International Security, where she has engaged events promoting scientific literacy and bridging the gap between scientists and educators, policy makers, government officials, and the public.
Wilson is currently president of the Champaign-Urbana Branch of the American Association for University Women, where she helps organize and convene community outreach events aimed at advancing equity and higher education opportunities for women and girls, particularly in STEM areas. As director for undergraduate education in the School of Molecular and Cellular Biology, she helps oversee the delivery of all academic, advising, and curricular aspects of the BS in MCB, BS in Biochemistry, BS in Neuroscience, and the forthcoming BS in MCB + Data Science undergraduate programs and the MS in MCB graduate programs. As the Sandia Senior Faculty Fellow in the Office of the Vice-Chancellor for Research and Innovation, she fosters, engages, and sustains research collaborations in STEM disciplines, including building workforce pipelines between scientists at the University of Illinois and the U.S. Department of Energy's national labs.
Research interests
Wilson’s research focuses on the host-microbe interface, bacterial pathogenesis and bacterial protein toxins, development of anti-toxin and toxin-based therapeutic biologics, comparative and functional genomic technologies and applications involving microbiomes and their roles in health and disease, climate change impacts on microbiomes, health, and disease transmission, and development of technologies and applications for detection and risk assessment of Dual Use Research of Concern (DURC) objects, publications, and activities. She has published over 150 scientific articles, chapters, and books, including the highly acclaimed textbook Bacterial Pathogenesis: A Molecular Approach (4th Edition, 2019, ASM Press/John Wiley) and the recent Revenge of the Microbes: How Bacterial Resistance is Undermining the Antibiotic Miracle (2nd Edition, 2023, ASM Press/John Wiley).
Education
BA (Biochemistry and German), Barnard College/Columbia University, 1981
Biochemistry Diplomarbeit (Post-baccalaureate Program), Deutscher Akademischer Austauschdienst (DAAD), Ludwig-Maximilians Universität, Munich, Germany, 1981-1982
M.S./Ph.D. (Chemistry), Johns Hopkins University, 1989
Postdoctoral (Microbiology and Molecular Genetics), Harvard Medical School, 1989-1993
Website

Faraz Harsini, PhD, is a scientist specializing in biotechnology, molecular biophysics, and protein engineering. As a Senior Scientist at the Good Food Institute (GFI), he analyzes how best to scale the cultivated meat industry and ensure these products can enter and grow in the marketplace as quickly as possible. With a PhD in Cell Physiology and Molecular Biophysics from Texas Tech University Health Sciences Center (TTUHSC), his research focused on protein structure and function, particularly in muscle repair and muscular dystrophies. Prior to GFI, he worked in biopharma as a Protein Expression and Process Development Scientist, contributing to the discovery of novel therapeutic proteins and leading pilot studies in process development and formulation.
His expertise spans biotechnology, cultivated meat, and technical analysis. Faraz is also certified in lifestyle medicine by the American College of Lifestyle Medicine, reflecting his interest in the intersection of science, health, and nutrition.